Literature DB >> 22510379

Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study.

Atsuhiro Kanno1, Masahiro Kikuya, Takayoshi Ohkubo, Takanao Hashimoto, Michihiro Satoh, Takuo Hirose, Taku Obara, Hirohito Metoki, Ryusuke Inoue, Kei Asayama, Yoh Shishido, Haruhisa Hoshi, Masaaki Nakayama, Kazuhito Totsune, Hiroshi Satoh, Hiroshi Sato, Yutaka Imai.   

Abstract

BACKGROUND: Hypertension is associated with an increased risk of development of chronic kidney disease (CKD). However, it is unclear whether pre-hypertension is related to the incidence of CKD.
METHODS: The incidence of CKD defined as positive proteinuria or estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) was examined in 2150 inhabitants without pre-existing CKD from the general Japanese population. The association of blood pressure and CKD incidence was examined using a Cox regression model adjusted for age, sex, habitual smoking and drinking, obesity, history of cardiovascular disease, diabetes mellitus or hypercholesterolemia, eGFR at baseline, number of follow-up examinations and year of baseline examination. Participants were categorized according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure.
RESULTS: Participants were categorized into normotension (n = 586, 27.3 % ), pre-hypertension (n = 815, 37.9 % ), Stage 1 hypertension (n = 386, 18.0 % ) and Stage 2 hypertension (n = 363, 16.9 % ). During a mean follow-up of 6.5 years (14 023 person-years), 461 incidences of CKD were recorded. Compared to normotension, adjusted hazard ratios of CKD were significantly higher for pre-hypertension (1.49, P < 0.003), Stage 1 (1.83, P < 0.001) and Stage 2 (2.55, P < 0.001) hypertension. The population-attributable fraction of pre-hypertension (12.1 % ) was considered to be compatible to that of Stage 1 (8.6 % ) and Stage 2 (14.9 % ) hypertension.
CONCLUSION: This was the first study to demonstrate that pre-hypertension was significantly associated with an increased risk of CKD and was one of the considerable causes of CKD in the general population.

Entities:  

Mesh:

Year:  2012        PMID: 22510379     DOI: 10.1093/ndt/gfs054

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Relationship between prehypertension and incidence of chronic kidney disease in a general population: a prospective analysis in central south China.

Authors:  Xia Cao; Xiumei Xie; Jiansong Zhou; Hong Yuan; Zhiheng Chen
Journal:  Int Urol Nephrol       Date:  2014-08-19       Impact factor: 2.370

2.  Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease.

Authors:  Akihiro Tsuchimoto; Shigeru Tanaka; Hiromasa Kitamura; Hiroto Hiyamuta; Kazuhiko Tsuruya; Takanari Kitazono; Toshiaki Nakano
Journal:  Clin Exp Nephrol       Date:  2022-08-04       Impact factor: 2.617

3.  An epidemiological study determining blood pressure in a Portuguese cohort: the Guimarães/Vizela study.

Authors:  P G Cunha; J Cotter; P Oliveira; I Vila; N Sousa
Journal:  J Hum Hypertens       Date:  2014-07-31       Impact factor: 3.012

4.  Prevalence and determinants of pre-hypertension and hypertension among the adults in rural Bangladesh: findings from a community-based study.

Authors:  Masuma Akter Khanam; Wietze Lindeboom; Abdur Razzaque; Louis Niessen; Abul Hasnat Milton
Journal:  BMC Public Health       Date:  2015-02-28       Impact factor: 3.295

5.  A Meta-Analysis on Prehypertension and Chronic Kidney Disease.

Authors:  Yang Li; Peng Xia; Lubin Xu; Yang Wang; Limeng Chen
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

6.  The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis.

Authors:  Misghina Weldegiorgis; Mark Woodward
Journal:  BMC Nephrol       Date:  2020-11-25       Impact factor: 2.388

7.  Chronic kidney disease is characterized by "double trouble" higher pulse pressure plus night-time systolic blood pressure and more severe cardiac damage.

Authors:  Massimiliano Fedecostante; Francesco Spannella; Giovanna Cola; Emma Espinosa; Paolo Dessì-Fulgheri; Riccardo Sarzani
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

8.  Prehypertension and Chronic Kidney Disease in Chinese Population: Four-Year Follow-Up Study.

Authors:  Hao Xue; Jianli Wang; Jinhong Hou; Junjuan Li; Jingsheng Gao; Shuohua Chen; Hang Zhu; Shouling Wu
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

9.  Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?

Authors:  Ryotaro Bouchi; Norihiko Ohara; Masahiro Asakawa; Yujiro Nakano; Takato Takeuchi; Masanori Murakami; Yuriko Sasahara; Mitsuyuki Numasawa; Isao Minami; Hajime Izumiyama; Koshi Hashimoto; Takanobu Yoshimoto; Yoshihiro Ogawa
Journal:  Cardiovasc Diabetol       Date:  2016-01-21       Impact factor: 9.951

10.  Blood Pressure and Chronic Kidney Disease Stratified by Gender and the Use of Antihypertensive Drugs.

Authors:  Michihiro Satoh; Takuo Hirose; Shingo Nakayama; Takahisa Murakami; Kyosuke Takabatake; Kei Asayama; Yutaka Imai; Takayoshi Ohkubo; Takefumi Mori; Hirohito Metoki
Journal:  J Am Heart Assoc       Date:  2020-08-14       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.